Kaleido Biosciences (OTC:KLDO) Stock, Quote.Headers.trade-ideas

Kaleido Biosciences

Kaleido Biosciences Inc is a clinical-stage healthcare company. It is focused on leveraging the potential of the microbiome organ to treat disease and improve human health. Its product candidates are Microbiome Metabolic Therapies, or MMTs, which are designed to modulate the metabolic output and profile of the microbiome.

Biotech

Earnings

News

Penny Stocks

Small Cap

General

ANTX

ISRG

KLDO

LYRA

OCUL

PSTV

REGN

SRRA

TGTX

Biotech stocks retreated in the week ending April 14, lock-stepping with the broader market. The news flow was light during the holiday-shortened week and ahead of the imminent first-quarter reporting season.

The Week Ahead In Biotech (April 17-April 23): J&amp;J, Abbott Earnings, Adcom Test For TG Therapeutics And More

Health Care

Movers

Trading Ideas

Kaleido Biosciences Shares Plunging To 52-Week Low, Read Why

Price Target

Analyst Ratings

Kaleido Biosciences Inc (NASDAQ: KLDO) halted work on a planned phase 2 trial in chronic obstructive pulmonary disease (COPD) and 

Kaleido Halts Upcoming Phase 2 COPD Trial, Piper Sandler Cuts Price Target

KALEIDO BIOSCIENCES INC by Kaleido Biosciences, Inc.

Kaleido Biosciences Inc

Comments

Kaleido Biosciences

Kaleido Biosciences (OTC:KLDO) Stock, Quote.Headers.trade-ideas

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell